Picture of Asterasys Co logo

450950 Asterasys Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapNeutral

Annual cashflow statement for Asterasys Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUSAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinal
Net Income/Starting Line1,2118725,3529,210
Depreciation
Amortisation
Non-Cash Items1,1901,1362,4511,732
Unusual Items
Other Non-Cash Items
Changes in Working Capital92.2-1,907-5,025-7,751
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities3,5631,4854,3624,986
Capital Expenditures-930-1,601-1,235-1,499
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-41.45.91-75.4-18,265
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-971-1,595-1,310-19,764
Financing Cash Flow Items-10511.1-731
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-548-606-60915,565
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1,986-7362,498763